New Technology Aims to Improve Buprenorphine Treatment in Young Adults

June 23rd, 2016

The National Institute on Drug Abuse (NIDA) is funding two pilot studies led by board-certified addiction psychiatrist Dr. Zev Schuman-Olivier. The studies will explore the use of MySafeRx by young adults ages 18-34 who have been prescribed buprenorphine but continue to use illicit opioids or who have had a relapse.

Learn More


Posted in Content

A Project of the Governor's Institute on Alcohol & Substance Abuse and the North Carolina Society of Addiction Medicine.
Funded wholly or in part by the federal Substance Abuse Prevention and Treatment Block Grant Fund (CFDA #93.959) as a project of the NC Division of Mental Health, Developmental Disabilities & Substance Abuse Services.